Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by PinnacleXon Jan 17, 2021 1:28am
178 Views
Post# 32314676

RE:Dubious deal?

RE:Dubious deal?
Lee430 wrote: I am simply an average retail investor that just took a big hit thanks to this dubious deal, so unless we find out soon that there was a justifiable reason for what appears on the surface to be a VERY poor deal, I would like to ask the experienced people on this board if we should consider contributing to a fund that would pay to investigate this….Could it be possible that there was some sort of backroom deal here that threw us under the bus and lined some pockets?.....I really have no clue as this is way over my skill set but thought it should be at least debated….If this is out of line, my apologies as I am stuck in the denial/anger phase.
 




LOL its callled a lawsuit not a fund, and Ive been calling for this for over a year now, these are incompetant people running this company. 
<< Previous
Bullboard Posts
Next >>